Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and Grading
暂无分享,去创建一个
B. Scheithauer | J. Buckner | A. Weaver | M. Graeber | P. Burger | J. Kros | G. Keeney | C. Giannini | H. Tazelaar | P. Pernicone | S. Mørk | T. Crotty | A. Nascimento | C. GIANNINI | B. W. SCHEITHAUER | A. L. WEAVER | P. C. BURGER | J. M. KROS | S. MORK | M. B. GRAEBER | S. BAUSERMAN | J. C. BUCKNER | J. BURTON | R. RIEPE | H. D. TAZELAAR | T. CROTTY | G. L. KEENEY | P. PERNICONE | H. ALTERMATT | R. Riepe | H. Altermatt | J. Burton | S. Bauserman | James Burton
[1] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[2] R. McLendon,et al. Clinicopathologic correlations in the oligodendroglioma , 1987, Cancer.
[3] S. Coons,et al. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. , 1997, Neurosurgery.
[4] D. Troost,et al. Oligodendroglioma. A comparison of two grading systems , 1988, Cancer.
[5] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[6] B. Scheithauer,et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.
[7] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[8] G. Eide,et al. Oligodendroglioma. Histologic Evaluation and Prognosis , 1986, Journal of neuropathology and experimental neurology.
[9] J. Kros,et al. Prognostic value of the proliferation‐related antigen Ki‐67 in oligodendrogliomas , 1996, Cancer.
[10] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.
[11] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] V. Armbrustmacher,et al. Grading of oligodendrogliomas , 1983, Cancer.
[13] M. Brada. Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.
[14] H. Korf,et al. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases , 1998, Acta Neuropathologica.
[15] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[16] A. Bowker,et al. A test for symmetry in contingency tables. , 1948, Journal of the American Statistical Association.
[17] B. Scheithauer,et al. Histological Classification of Tumours of the Central Nervous System , 1993 .
[18] P. Bailey,et al. Oligodendrogliomas of the brain , 1929 .
[19] G. Fuller,et al. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice , 1997, Cancer.
[20] L. Rorke. Pathologic diagnosis as the gold standard , 1997, Cancer.
[21] R. Mccomb,et al. Pathology and Genetics of Tumours of the Nervous System , 1998 .
[22] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[23] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.
[24] S. Coons,et al. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. , 1994, Neurosurgery.
[25] A. Poustka,et al. Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors , 2000, Journal of neuropathology and experimental neurology.
[26] Michael F Gonzales,et al. Grading of gliomas , 1997, Journal of Clinical Neuroscience.